gms | German Medical Science

77. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

24.05. - 28.05.2006, Mannheim

Diagnostics and therapy of malignant tumors of the parotid gland - a retrospective analysis of 60 cases

Meeting Abstract

Suche in Medline nach

  • corresponding author presenting/speaker Matthias Scheich - Univ.-HNO Klinik, Würzburg, Germany
  • Alessandro Relic - Univ.-HNO Klinik, Würzburg, Germany
  • Rudolf Hagen - Univ.-HNO Klinik, Würzburg, Germany

German Society of Otorhinolaryngology, Head and Neck Surgery. 77th Annual Meeting of the German Society of Otorhinolaryngology, Head and Neck Surgery. Mannheim, 24.-28.05.2006. Düsseldorf, Köln: German Medical Science; 2006. Doc06hno095

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/hno2006/06hno095.shtml

Veröffentlicht: 7. September 2006

© 2006 Scheich et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielf&aauml;ltigt, verbreitet und &oauml;ffentlich zug&aauml;nglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Introduction: Malignant tumors of the parotid gland are rare. They affect less than 20% of all tumors of the parotid gland and they need special diagnostics and therapy.

Methods: The records of 60 patients from 2000 and 2005 with a primary malignancy of the parotid gland were reviewed retrospectively. Recurrencies and metastases in the parotid gland were excluded.

Results: Adenocarcinomas (20%) and Mucoepidermoidcarcinomas (16%) were the most common tumors. There were 12 T1-, 22 T2-, 15 T3- and 11 T4-tumors with 40 N0-, 4 N1-, 13 N2b- and 3 N3- necks. Two patients showed with distant metastases.

55 patients could be treated by operation and 43 received postoperative radiotherapy. In 65% of the cases, the neck dissection was done during the parotidectomy, whereas in 21% of the cases it was done in a second operation. The facial nerve had to be resected (partially) in 36% of the operations. One third of the patients had a (partial) facial nerve palsy preoperatively.

Conclusions: First-line treatment of malignant tumors of the parotid gland should be the complete resection. A neck dissection and/or radiotherapy should be considered according to histology and tumor size.